Lack of FasL expression in cultured human retinal pigment epithelial cells.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Lack of FasL expression in cultured human retinal pigment epithelial cells. / Kaestel, C G; Madsen, H O; Prause, J U; Jørgensen, A; Liang, Y; la Cour , M; Lui, G M; Odum, N; Nissen, Mogens Holst; Röpke, C.

I: Experimental and Clinical Immunogenetics, Bind 18, Nr. 1, 2001, s. 34-41.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Kaestel, CG, Madsen, HO, Prause, JU, Jørgensen, A, Liang, Y, la Cour , M, Lui, GM, Odum, N, Nissen, MH & Röpke, C 2001, 'Lack of FasL expression in cultured human retinal pigment epithelial cells.', Experimental and Clinical Immunogenetics, bind 18, nr. 1, s. 34-41.

APA

Kaestel, C. G., Madsen, H. O., Prause, J. U., Jørgensen, A., Liang, Y., la Cour , M., Lui, G. M., Odum, N., Nissen, M. H., & Röpke, C. (2001). Lack of FasL expression in cultured human retinal pigment epithelial cells. Experimental and Clinical Immunogenetics, 18(1), 34-41.

Vancouver

Kaestel CG, Madsen HO, Prause JU, Jørgensen A, Liang Y, la Cour M o.a. Lack of FasL expression in cultured human retinal pigment epithelial cells. Experimental and Clinical Immunogenetics. 2001;18(1):34-41.

Author

Kaestel, C G ; Madsen, H O ; Prause, J U ; Jørgensen, A ; Liang, Y ; la Cour , M ; Lui, G M ; Odum, N ; Nissen, Mogens Holst ; Röpke, C. / Lack of FasL expression in cultured human retinal pigment epithelial cells. I: Experimental and Clinical Immunogenetics. 2001 ; Bind 18, Nr. 1. s. 34-41.

Bibtex

@article{d7a38f80ba3011ddae57000ea68e967b,

title = "Lack of FasL expression in cultured human retinal pigment epithelial cells.",

abstract = "Retinal pigment epithelial (RPE) cells have been proposed to play a part in maintaining the eye as an immune privileged organ. However, our knowledge of the implicated mechanism is still sparse. Fas ligand (FasL) expression of RPE cells is generally recognized to be essential for the immune privilege of the eye, but due to contradictory published results, it is unclear whether RPE cells express this molecule. The purpose of this study was to investigate the expression of FasL in RPE cells in vitro and in vivo. Cultured human fetal and adult RPE cells were examined by flow cytometry, Western blotting, RT-PCR and RNase Protection assay for FasL expression. Additionally, sections of ocular tissue were stained for FasL by immunohistochemistry. None of the used methods indicated FasL expression in cultured fetal or adult RPE cells of various passages. However, RPE cells in vivo, as judged from tissue sections, were positive for FasL, indicating a discrepancy between RPE cells in vitro and in vivo with regard to this molecule.",

author = "Kaestel, {C G} and Madsen, {H O} and Prause, {J U} and A J{\o}rgensen and Y Liang and {la Cour}, M and Lui, {G M} and N Odum and Nissen, {Mogens Holst} and C R{\"o}pke",

note = "Keywords: Adult; Antigens, CD95; Blotting, Western; Cell Line; Fas Ligand Protein; Fetus; Flow Cytometry; Humans; Immune Sera; Immunohistochemistry; Ligands; Membrane Glycoproteins; Pigment Epithelium of Eye; RNA, Messenger; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleases",

year = "2001",

language = "English",

volume = "18",

pages = "34--41",

journal = "Experimental and Clinical Immunogenetics",

issn = "0254-9670",

publisher = "S Karger AG",

number = "1",

}

RIS

TY - JOUR

T1 - Lack of FasL expression in cultured human retinal pigment epithelial cells.

AU - Kaestel, C G

AU - Madsen, H O

AU - Prause, J U

AU - Jørgensen, A

AU - Liang, Y

AU - la Cour , M

AU - Lui, G M

AU - Odum, N

AU - Nissen, Mogens Holst

AU - Röpke, C

N1 - Keywords: Adult; Antigens, CD95; Blotting, Western; Cell Line; Fas Ligand Protein; Fetus; Flow Cytometry; Humans; Immune Sera; Immunohistochemistry; Ligands; Membrane Glycoproteins; Pigment Epithelium of Eye; RNA, Messenger; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleases

PY - 2001

Y1 - 2001

N2 - Retinal pigment epithelial (RPE) cells have been proposed to play a part in maintaining the eye as an immune privileged organ. However, our knowledge of the implicated mechanism is still sparse. Fas ligand (FasL) expression of RPE cells is generally recognized to be essential for the immune privilege of the eye, but due to contradictory published results, it is unclear whether RPE cells express this molecule. The purpose of this study was to investigate the expression of FasL in RPE cells in vitro and in vivo. Cultured human fetal and adult RPE cells were examined by flow cytometry, Western blotting, RT-PCR and RNase Protection assay for FasL expression. Additionally, sections of ocular tissue were stained for FasL by immunohistochemistry. None of the used methods indicated FasL expression in cultured fetal or adult RPE cells of various passages. However, RPE cells in vivo, as judged from tissue sections, were positive for FasL, indicating a discrepancy between RPE cells in vitro and in vivo with regard to this molecule.

AB - Retinal pigment epithelial (RPE) cells have been proposed to play a part in maintaining the eye as an immune privileged organ. However, our knowledge of the implicated mechanism is still sparse. Fas ligand (FasL) expression of RPE cells is generally recognized to be essential for the immune privilege of the eye, but due to contradictory published results, it is unclear whether RPE cells express this molecule. The purpose of this study was to investigate the expression of FasL in RPE cells in vitro and in vivo. Cultured human fetal and adult RPE cells were examined by flow cytometry, Western blotting, RT-PCR and RNase Protection assay for FasL expression. Additionally, sections of ocular tissue were stained for FasL by immunohistochemistry. None of the used methods indicated FasL expression in cultured fetal or adult RPE cells of various passages. However, RPE cells in vivo, as judged from tissue sections, were positive for FasL, indicating a discrepancy between RPE cells in vitro and in vivo with regard to this molecule.

M3 - Journal article

C2 - 11150851

VL - 18

SP - 34

EP - 41

JO - Experimental and Clinical Immunogenetics

JF - Experimental and Clinical Immunogenetics

SN - 0254-9670

IS - 1

ER -

ID: 8746336